Scholarship and Biography
John Keilty, MS, is a Venture Partner at Third Rock Ventures, a firm that specializes on the ideation, development and launch of new biotechnology companies focusing on areas of unmet medical need. Mr. Keilty concentrates on the establishment and roll-out of bio/cheminformatics, automation and science platform technologies intended to impact the entire drug development life-cycle. He has played key roles in many companies including Thrive Detect and Decibel Therapeutics where he served as interim-CDO and Chief Data Sciences Officer, respectively.
Prior to TRV, Mr. Keilty was the Vice President, Information Technology and Informatics at Infinity Pharmaceuticals where he was responsible for information systems, software development, structural biology, bioinformatics, and clinical informatics. Early in his career, Mr. Keilty was an early member of a nascent Millennium Pharmaceuticals where he had broad ownership for the creation, management, implementation and transfer of much of the company's core genomic technologies.